K
Kalaris Therapeutics, Inc. (KLRS)
NGM – Real vaqt narxi. Valyuta: USD
4.79
+0.06 (1.27%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
4.79
+0.06 (1.27%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $19.00 based on the ratings of 5 analysts. The high is $23.00 and the low is $14.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 14 | $ 19 | $ 23 |
| O’zgarish | 175.59% | 274.02% | 352.76% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-16 | 175.59% | Morgan Stanley | $14 | Initiates Coverage On | Overweight |
| 2025-12-23 | 274.02% | Chardan Capital | $19 | Initiates Coverage On | Buy |
| 2025-11-03 | 293.7% | Citizens | $20 | Initiates Coverage On | Market Outperform |
| 2025-09-03 | 352.76% | Raymond James | $23 | Initiates Coverage On | Strong Buy |
| 2025-04-08 | — | William Blair | — | Initiates Coverage On | Outperform |